Ms Firth says the initiative will provide a single point
of contact for overseas researchers and pharmaceutical and medical technology
companies.
“It also helps us attract and retain world-class
clinicians, researchers and scientists, and makes NSW attractive for them to be
in,” she said.
“It also provides a mechanism for further development
of products at home so that our researchers don’t have to go overseas to
attract international investment.”
She says the initiative is designed to ensure the state’s
future economic prosperity is not reliant on short-term resource booms.
“The reason why it’s so important is that the global
clinical trials industry is worth $10 billion,” she said.
“Global revenues from clinical trials increased by 15
per cent in the last year alone, so it’s obviously worth a lot of money.”
http://abc.net.au/news/stories/2007/09/24/2041279.htm
http://www.osmr.nsw.gov.au/lsra_round2/nsw_clinical_trials_centre